TFF Pharmaceuticals Statistics
Share Statistics
TFF Pharmaceuticals has 4.44M
shares outstanding. The number of shares has increased by 43.41%
in one year.
| Shares Outstanding | 4.44M |
| Shares Change (YoY) | 43.41% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 31.87% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 655 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 157.16K, so 3.54% of the outstanding
shares have been sold short.
| Short Interest | 157.16K |
| Short % of Shares Out | 3.54% |
| Short % of Float | 3.57% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.59 and the forward
PE ratio is null.
TFF Pharmaceuticals's PEG ratio is
0.01.
| PE Ratio | -0.59 |
| Forward PE | n/a |
| PS Ratio | 17.15 |
| Forward PS | n/a |
| PB Ratio | 1.32 |
| P/FCF Ratio | -0.78 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
TFF Pharmaceuticals has an Enterprise Value (EV) of 7.22M.
| EV / Sales | 9.84 |
| EV / EBITDA | -0.35 |
| EV / EBIT | -0.45 |
| EV / FCF | -0.45 |
Financial Position
The company has a current ratio of 3.13,
with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.13 |
| Quick Ratio | 3.13 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is -222.05% and Return on Invested Capital is -226.13%.
| Return on Equity | -222.05% |
| Return on Assets | -176.62% |
| Return on Invested Capital | -226.13% |
| Revenue Per Employee | $38,624.79 |
| Profits Per Employee | $-1,118,064.79 |
| Employee Count | 19 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -97.67% in the
last 52 weeks. The beta is 1.32, so TFF Pharmaceuticals's
price volatility has been higher than the market average.
| Beta | 1.32 |
| 52-Week Price Change | -97.67% |
| 50-Day Moving Average | 0.63 |
| 200-Day Moving Average | 1.92 |
| Relative Strength Index (RSI) | 20.19 |
| Average Volume (20 Days) | 1,687,665 |
Income Statement
In the last 12 months, TFF Pharmaceuticals had revenue of 733.87K
and earned -21.24M
in profits. Earnings per share was -11.85.
| Revenue | 733.87K |
| Gross Profit | 231.39K |
| Operating Income | -21.89M |
| Net Income | -21.24M |
| EBITDA | -20.74M |
| EBIT | -21.24M |
| Earnings Per Share (EPS) | -11.85 |
Full Income StatementBalance Sheet
The company has 5.48M in cash and 115.25K in
debt, giving a net cash position of 5.36M.
| Cash & Cash Equivalents | 5.48M |
| Total Debt | 115.25K |
| Net Cash | 5.36M |
| Retained Earnings | -118.33M |
| Total Assets | 7.08M |
| Working Capital | -432.35K |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -16.04M
and capital expenditures -94.75K, giving a free cash flow of -16.13M.
| Operating Cash Flow | -16.04M |
| Capital Expenditures | -94.75K |
| Free Cash Flow | -16.13M |
| FCF Per Share | -9 |
Full Cash Flow StatementMargins
Gross margin is 31.53%, with operating and profit margins of -2983.45% and -2894.68%.
| Gross Margin | 31.53% |
| Operating Margin | -2983.45% |
| Pretax Margin | -2894.68% |
| Profit Margin | -2894.68% |
| EBITDA Margin | -2826.21% |
| EBIT Margin | -2983.45% |
| FCF Margin | -2198.34% |
